Global Ketorolac Market Size, Status and Forecast 2021-2027

Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.It's analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis.12 Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.

Market Analysis and Insights: Global Ketorolac Market

The global Ketorolac market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ketorolac market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ketorolac market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ketorolac market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ketorolac market.

Global Ketorolac Scope and Market Size

Ketorolac market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ketorolac market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Tablets

Injection

Eye Drops

Capsule

Postoperative Pain

Acute Renal Colic

Biliary Colic

Toothache

And The Pain

Trigeminal Neuralgia

Cancer Visceral Pain

Seasonal Allergic Conjunctivitis

Other

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Pfizer

Femina Pharma

Fuisz Pharma

Allergan

Technical Chemicals & Products

Apotex Corporation

Sichuan Meida Kangjiale Pharmaceutical

Tianjin Hongri Pharmaceutical

Shandong New Era Pharmaceutical

Chengdu Better Pharmaceutical

Yongxin Pharmaceutical Industry

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ketorolac Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Tablets

1.2.3 Injection

1.2.4 Eye Drops

1.2.5 Capsule

1.3 Market by Application

1.3.1 Global Ketorolac Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Postoperative Pain

1.3.3 Acute Renal Colic

1.3.4 Biliary Colic

1.3.5 Toothache

1.3.6 And The Pain

1.3.7 Trigeminal Neuralgia

1.3.8 Cancer Visceral Pain

1.3.9 Seasonal Allergic Conjunctivitis

1.3.10 Other

1.4 Study Objectives

1.5 Years Considered

2.1 Global Ketorolac Market Perspective (2016-2027)

2.2 Ketorolac Growth Trends by Regions

2.2.1 Ketorolac Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Ketorolac Historic Market Share by Regions (2016-2021)

2.2.3 Ketorolac Forecasted Market Size by Regions (2022-2027)

2.3 Ketorolac Industry Dynamic

2.3.1 Ketorolac Market Trends

2.3.2 Ketorolac Market Drivers

2.3.3 Ketorolac Market Challenges

2.3.4 Ketorolac Market Restraints

3.1 Global Top Ketorolac Players by Revenue

3.1.1 Global Top Ketorolac Players by Revenue (2016-2021)

3.1.2 Global Ketorolac Revenue Market Share by Players (2016-2021)

3.2 Global Ketorolac Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Ketorolac Revenue

3.4 Global Ketorolac Market Concentration Ratio

3.4.1 Global Ketorolac Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ketorolac Revenue in 2020

3.5 Ketorolac Key Players Head office and Area Served

3.6 Key Players Ketorolac Product Solution and Service

3.7 Date of Enter into Ketorolac Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Ketorolac Historic Market Size by Type (2016-2021)

4.2 Global Ketorolac Forecasted Market Size by Type (2022-2027)

5.1 Global Ketorolac Historic Market Size by Application (2016-2021)

5.2 Global Ketorolac Forecasted Market Size by Application (2022-2027)

6.1 North America Ketorolac Market Size (2016-2027)

6.2 North America Ketorolac Market Size by Type

6.2.1 North America Ketorolac Market Size by Type (2016-2021)

6.2.2 North America Ketorolac Market Size by Type (2022-2027)

6.2.3 North America Ketorolac Market Size by Type (2016-2027)

6.3 North America Ketorolac Market Size by Application

6.3.1 North America Ketorolac Market Size by Application (2016-2021)

6.3.2 North America Ketorolac Market Size by Application (2022-2027)

6.3.3 North America Ketorolac Market Size by Application (2016-2027)

6.4 North America Ketorolac Market Size by Country

6.4.1 North America Ketorolac Market Size by Country (2016-2021)

6.4.2 North America Ketorolac Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7.1 Europe Ketorolac Market Size (2016-2027)

7.2 Europe Ketorolac Market Size by Type

7.2.1 Europe Ketorolac Market Size by Type (2016-2021)

7.2.2 Europe Ketorolac Market Size by Type (2022-2027)

7.2.3 Europe Ketorolac Market Size by Type (2016-2027)

7.3 Europe Ketorolac Market Size by Application

7.3.1 Europe Ketorolac Market Size by Application (2016-2021)

7.3.2 Europe Ketorolac Market Size by Application (2022-2027)

7.3.3 Europe Ketorolac Market Size by Application (2016-2027)

7.4 Europe Ketorolac Market Size by Country

7.4.1 Europe Ketorolac Market Size by Country (2016-2021)

7.4.2 Europe Ketorolac Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8.1 Asia-Pacific Ketorolac Market Size (2016-2027)

8.2 Asia-Pacific Ketorolac Market Size by Type

8.2.1 Asia-Pacific Ketorolac Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Ketorolac Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Ketorolac Market Size by Type (2016-2027)

8.3 Asia-Pacific Ketorolac Market Size by Application

8.3.1 Asia-Pacific Ketorolac Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Ketorolac Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Ketorolac Market Size by Application (2016-2027)

8.4 Asia-Pacific Ketorolac Market Size by Region

8.4.1 Asia-Pacific Ketorolac Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Ketorolac Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Ketorolac Market Size (2016-2027)

9.2 Latin America Ketorolac Market Size by Type

9.2.1 Latin America Ketorolac Market Size by Type (2016-2021)

9.2.2 Latin America Ketorolac Market Size by Type (2022-2027)

9.2.3 Latin America Ketorolac Market Size by Type (2016-2027)

9.3 Latin America Ketorolac Market Size by Application

9.3.1 Latin America Ketorolac Market Size by Application (2016-2021)

9.3.2 Latin America Ketorolac Market Size by Application (2022-2027)

9.3.3 Latin America Ketorolac Market Size by Application (2016-2027)

9.4 Latin America Ketorolac Market Size by Country

9.4.1 Latin America Ketorolac Market Size by Country (2016-2021)

9.4.2 Latin America Ketorolac Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Ketorolac Market Size (2016-2027)

10.2 Middle East & Africa Ketorolac Market Size by Type

10.2.1 Middle East & Africa Ketorolac Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Ketorolac Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Ketorolac Market Size by Type (2016-2027)

10.3 Middle East & Africa Ketorolac Market Size by Application

10.3.1 Middle East & Africa Ketorolac Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Ketorolac Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Ketorolac Market Size by Application (2016-2027)

10.4 Middle East & Africa Ketorolac Market Size by Country

10.4.1 Middle East & Africa Ketorolac Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Ketorolac Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Ketorolac Introduction

11.1.4 Pfizer Revenue in Ketorolac Business (2016-2021)

11.1.5 Pfizer Recent Development

11.2 Femina Pharma

11.2.1 Femina Pharma Company Details

11.2.2 Femina Pharma Business Overview

11.2.3 Femina Pharma Ketorolac Introduction

11.2.4 Femina Pharma Revenue in Ketorolac Business (2016-2021)

11.2.5 Femina Pharma Recent Development

11.3 Fuisz Pharma

11.3.1 Fuisz Pharma Company Details

11.3.2 Fuisz Pharma Business Overview

11.3.3 Fuisz Pharma Ketorolac Introduction

11.3.4 Fuisz Pharma Revenue in Ketorolac Business (2016-2021)

11.3.5 Fuisz Pharma Recent Development

11.4 Allergan

11.4.1 Allergan Company Details

11.4.2 Allergan Business Overview

11.4.3 Allergan Ketorolac Introduction

11.4.4 Allergan Revenue in Ketorolac Business (2016-2021)

11.4.5 Allergan Recent Development

11.5 Technical Chemicals & Products

11.5.1 Technical Chemicals & Products Company Details

11.5.2 Technical Chemicals & Products Business Overview

11.5.3 Technical Chemicals & Products Ketorolac Introduction

11.5.4 Technical Chemicals & Products Revenue in Ketorolac Business (2016-2021)

11.5.5 Technical Chemicals & Products Recent Development

11.6 Apotex Corporation

11.6.1 Apotex Corporation Company Details

11.6.2 Apotex Corporation Business Overview

11.6.3 Apotex Corporation Ketorolac Introduction

11.6.4 Apotex Corporation Revenue in Ketorolac Business (2016-2021)

11.6.5 Apotex Corporation Recent Development

11.7 Sichuan Meida Kangjiale Pharmaceutical

11.7.1 Sichuan Meida Kangjiale Pharmaceutical Company Details

11.7.2 Sichuan Meida Kangjiale Pharmaceutical Business Overview

11.7.3 Sichuan Meida Kangjiale Pharmaceutical Ketorolac Introduction

11.7.4 Sichuan Meida Kangjiale Pharmaceutical Revenue in Ketorolac Business (2016-2021)

11.7.5 Sichuan Meida Kangjiale Pharmaceutical Recent Development

11.8 Tianjin Hongri Pharmaceutical

11.8.1 Tianjin Hongri Pharmaceutical Company Details

11.8.2 Tianjin Hongri Pharmaceutical Business Overview

11.8.3 Tianjin Hongri Pharmaceutical Ketorolac Introduction

11.8.4 Tianjin Hongri Pharmaceutical Revenue in Ketorolac Business (2016-2021)

11.8.5 Tianjin Hongri Pharmaceutical Recent Development

11.9 Shandong New Era Pharmaceutical

11.9.1 Shandong New Era Pharmaceutical Company Details

11.9.2 Shandong New Era Pharmaceutical Business Overview

11.9.3 Shandong New Era Pharmaceutical Ketorolac Introduction

11.9.4 Shandong New Era Pharmaceutical Revenue in Ketorolac Business (2016-2021)

11.9.5 Shandong New Era Pharmaceutical Recent Development

11.10 Chengdu Better Pharmaceutical

11.10.1 Chengdu Better Pharmaceutical Company Details

11.10.2 Chengdu Better Pharmaceutical Business Overview

11.10.3 Chengdu Better Pharmaceutical Ketorolac Introduction

11.10.4 Chengdu Better Pharmaceutical Revenue in Ketorolac Business (2016-2021)

11.10.5 Chengdu Better Pharmaceutical Recent Development

11.11 Yongxin Pharmaceutical Industry

11.11.1 Yongxin Pharmaceutical Industry Company Details

11.11.2 Yongxin Pharmaceutical Industry Business Overview

11.11.3 Yongxin Pharmaceutical Industry Ketorolac Introduction

11.11.4 Yongxin Pharmaceutical Industry Revenue in Ketorolac Business (2016-2021)

11.11.5 Yongxin Pharmaceutical Industry Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Ketorolac Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

    Table 2. Key Players of Tablets

    Table 3. Key Players of Injection

    Table 4. Key Players of Eye Drops

    Table 5. Key Players of Capsule

    Table 6. Global Ketorolac Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

    Table 7. Global Ketorolac Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

    Table 8. Global Ketorolac Market Size by Regions (2016-2021) & (US$ Million)

    Table 9. Global Ketorolac Market Share by Regions (2016-2021)

    Table 10. Global Ketorolac Forecasted Market Size by Regions (2022-2027) & (US$ Million)

    Table 11. Global Ketorolac Market Share by Regions (2022-2027)

    Table 12. Ketorolac Market Trends

    Table 13. Ketorolac Market Drivers

    Table 14. Ketorolac Market Challenges

    Table 15. Ketorolac Market Restraints

    Table 16. Global Ketorolac Revenue by Players (2016-2021) & (US$ Million)

    Table 17. Global Ketorolac Market Share by Players (2016-2021)

    Table 18. Global Top Ketorolac Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ketorolac as of 2020)

    Table 19. Ranking of Global Top Ketorolac Companies by Revenue (US$ Million) in 2020

    Table 20. Global 5 Largest Players Market Share by Ketorolac Revenue (CR5 and HHI) & (2016-2021)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Ketorolac Product Solution and Service

    Table 23. Date of Enter into Ketorolac Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Ketorolac Market Size by Type (2016-2021) (US$ Million)

    Table 26. Global Ketorolac Revenue Market Share by Type (2016-2021)

    Table 27. Global Ketorolac Forecasted Market Size by Type (2022-2027) (US$ Million)

    Table 28. Global Ketorolac Revenue Market Share by Type (2022-2027) & (US$ Million)

    Table 29. Global Ketorolac Market Size Share by Application (2016-2021) & (US$ Million)

    Table 30. Global Ketorolac Revenue Market Share by Application (2016-2021)

    Table 31. Global Ketorolac Forecasted Market Size by Application (2022-2027) (US$ Million)

    Table 32. Global Ketorolac Revenue Market Share by Application (2022-2027) & (US$ Million)

    Table 33. North America Ketorolac Market Size by Type (2016-2021) (US$ Million)

    Table 34. North America Ketorolac Market Size by Type (2022-2027) & (US$ Million)

    Table 35. North America Ketorolac Market Size by Application (2016-2021) (US$ Million)

    Table 36. North America Ketorolac Market Size by Application (2022-2027) & (US$ Million)

    Table 37. North America Ketorolac Market Size by Country (2016-2021) & (US$ Million)

    Table 38. North America Ketorolac Market Size by Country (2022-2027) & (US$ Million)

    Table 39. Europe Ketorolac Market Size by Type (2016-2021) (US$ Million)

    Table 40. Europe Ketorolac Market Size by Type (2022-2027) & (US$ Million)

    Table 41. Europe Ketorolac Market Size by Application (2016-2021) (US$ Million)

    Table 42. Europe Ketorolac Market Size by Application (2022-2027) & (US$ Million)

    Table 43. Europe Ketorolac Market Size by Country (2016-2021) & (US$ Million)

    Table 44. Europe Ketorolac Market Size by Country (2022-2027) & (US$ Million)

    Table 45. Asia-Pacific Ketorolac Market Size by Type (2016-2021) (US$ Million)

    Table 46. Asia-Pacific Ketorolac Market Size by Type (2022-2027) & (US$ Million)

    Table 47. Asia-Pacific Ketorolac Market Size by Application (2016-2021) (US$ Million)

    Table 48. Asia-Pacific Ketorolac Market Size by Application (2022-2027) & (US$ Million)

    Table 49. Asia-Pacific Ketorolac Market Size by Region (2016-2021) & (US$ Million)

    Table 50. Asia-Pacific Ketorolac Market Size by Region (2022-2027) & (US$ Million)

    Table 51. Latin America Ketorolac Market Size by Type (2016-2021) (US$ Million)

    Table 52. Latin America Ketorolac Market Size by Type (2022-2027) & (US$ Million)

    Table 53. Latin America Ketorolac Market Size by Application (2016-2021) (US$ Million)

    Table 54. Latin America Ketorolac Market Size by Application (2022-2027) & (US$ Million)

    Table 55. Latin America Ketorolac Market Size by Country (2016-2021) & (US$ Million)

    Table 56. Latin America Ketorolac Market Size by Country (2022-2027) & (US$ Million)

    Table 57. Middle East & Africa Ketorolac Market Size by Type (2016-2021) (US$ Million)

    Table 58. Middle East & Africa Ketorolac Market Size by Type (2022-2027) & (US$ Million)

    Table 59. Middle East & Africa Ketorolac Market Size by Application (2016-2021) (US$ Million)

    Table 60. Middle East & Africa Ketorolac Market Size by Application (2022-2027) & (US$ Million)

    Table 61. Middle East & Africa Ketorolac Market Size by Country (2016-2021) & (US$ Million)

    Table 62. Middle East & Africa Ketorolac Market Size by Country (2022-2027) & (US$ Million)

    Table 63. Pfizer Company Details

    Table 64. Pfizer Business Overview

    Table 65. Pfizer Ketorolac Product

    Table 66. Pfizer Revenue in Ketorolac Business (2016-2021) & (US$ Million)

    Table 67. Pfizer Recent Development

    Table 68. Femina Pharma Company Details

    Table 69. Femina Pharma Business Overview

    Table 70. Femina Pharma Ketorolac Product

    Table 71. Femina Pharma Revenue in Ketorolac Business (2016-2021) & (US$ Million)

    Table 72. Femina Pharma Recent Development

    Table 73. Fuisz Pharma Company Details

    Table 74. Fuisz Pharma Business Overview

    Table 75. Fuisz Pharma Ketorolac Product

    Table 76. Fuisz Pharma Revenue in Ketorolac Business (2016-2021) & (US$ Million)

    Table 77. Fuisz Pharma Recent Development

    Table 78. Allergan Company Details

    Table 79. Allergan Business Overview

    Table 80. Allergan Ketorolac Product

    Table 81. Allergan Revenue in Ketorolac Business (2016-2021) & (US$ Million)

    Table 82. Allergan Recent Development

    Table 83. Technical Chemicals & Products Company Details

    Table 84. Technical Chemicals & Products Business Overview

    Table 85. Technical Chemicals & Products Ketorolac Product

    Table 86. Technical Chemicals & Products Revenue in Ketorolac Business (2016-2021) & (US$ Million)

    Table 87. Technical Chemicals & Products Recent Development

    Table 88. Apotex Corporation Company Details

    Table 89. Apotex Corporation Business Overview

    Table 90. Apotex Corporation Ketorolac Product

    Table 91. Apotex Corporation Revenue in Ketorolac Business (2016-2021) & (US$ Million)

    Table 92. Apotex Corporation Recent Development

    Table 93. Sichuan Meida Kangjiale Pharmaceutical Company Details

    Table 94. Sichuan Meida Kangjiale Pharmaceutical Business Overview

    Table 95. Sichuan Meida Kangjiale Pharmaceutical Ketorolac Product

    Table 96. Sichuan Meida Kangjiale Pharmaceutical Revenue in Ketorolac Business (2016-2021) & (US$ Million)

    Table 97. Sichuan Meida Kangjiale Pharmaceutical Recent Development

    Table 98. Tianjin Hongri Pharmaceutical Company Details

    Table 99. Tianjin Hongri Pharmaceutical Business Overview

    Table 100. Tianjin Hongri Pharmaceutical Revenue in Ketorolac Business (2016-2021) & (US$ Million)

    Table 101. Tianjin Hongri Pharmaceutical Recent Development

    Table 102. Shandong New Era Pharmaceutical Company Details

    Table 103. Shandong New Era Pharmaceutical Business Overview

    Table 104. Shandong New Era Pharmaceutical Ketorolac Product

    Table 105. Shandong New Era Pharmaceutical Revenue in Ketorolac Business (2016-2021) & (US$ Million)

    Table 106. Shandong New Era Pharmaceutical Recent Development

    Table 107. Chengdu Better Pharmaceutical Company Details

    Table 108. Chengdu Better Pharmaceutical Business Overview

    Table 109. Chengdu Better Pharmaceutical Ketorolac Product

    Table 110. Chengdu Better Pharmaceutical Revenue in Ketorolac Business (2016-2021) & (US$ Million)

    Table 111. Chengdu Better Pharmaceutical Recent Development

    Table 112. Yongxin Pharmaceutical Industry Company Details

    Table 113. Yongxin Pharmaceutical Industry Business Overview

    Table 114. Yongxin Pharmaceutical Industry Ketorolac Product

    Table 115. Yongxin Pharmaceutical Industry Revenue in Ketorolac Business (2016-2021) & (US$ Million)

    Table 116. Yongxin Pharmaceutical Industry Recent Development

    Table 117. Research Programs/Design for This Report

    Table 118. Key Data Information from Secondary Sources

    Table 119. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Ketorolac Market Share by Type: 2020 VS 2027

    Figure 2. Tablets Features

    Figure 3. Injection Features

    Figure 4. Eye Drops Features

    Figure 5. Capsule Features

    Figure 6. Global Ketorolac Market Share by Application: 2020 VS 2027

    Figure 7. Postoperative Pain Case Studies

    Figure 8. Acute Renal Colic Case Studies

    Figure 9. Biliary Colic Case Studies

    Figure 10. Toothache Case Studies

    Figure 11. And The Pain Case Studies

    Figure 12. Trigeminal Neuralgia Case Studies

    Figure 13. Cancer Visceral Pain Case Studies

    Figure 14. Seasonal Allergic Conjunctivitis Case Studies

    Figure 15. Other Case Studies

    Figure 16. Ketorolac Report Years Considered

    Figure 17. Global Ketorolac Market Size (US$ Million), Year-over-Year: 2016-2027

    Figure 18. Global Ketorolac Market Size (US$ Million), 2016 VS 2021 VS 2027

    Figure 19. Global Ketorolac Market Share by Regions: 2020 VS 2027

    Figure 20. Global Ketorolac Market Share by Regions (2022-2027)

    Figure 21. Global Ketorolac Market Share by Players in 2020

    Figure 22. Global Top Ketorolac Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ketorolac as of 2020

    Figure 23. The Top 10 and 5 Players Market Share by Ketorolac Revenue in 2020

    Figure 24. Global Ketorolac Revenue Market Share by Type (2016-2021)

    Figure 25. Global Ketorolac Revenue Market Share by Type (2022-2027)

    Figure 26. North America Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 27. North America Ketorolac Market Share by Type (2016-2027)

    Figure 28. North America Ketorolac Market Share by Application (2016-2027)

    Figure 29. North America Ketorolac Market Share by Country (2016-2027)

    Figure 30. United States Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 31. Canada Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 32. Europe Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 33. Europe Ketorolac Market Share by Type (2016-2027)

    Figure 34. Europe Ketorolac Market Share by Application (2016-2027)

    Figure 35. Europe Ketorolac Market Share by Country (2016-2027)

    Figure 36. Germany Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 37. France Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 38. U.K. Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 39. Italy Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 40. Russia Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 41. Nordic Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 42. Asia-Pacific Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 43. Asia-Pacific Ketorolac Market Share by Type (2016-2027)

    Figure 44. Asia-Pacific Ketorolac Market Share by Application (2016-2027)

    Figure 45. Asia-Pacific Ketorolac Market Share by Region (2016-2027)

    Figure 46. China Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 47. Japan Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 48. South Korea Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 49. Southeast Asia Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 50. India Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 51. Australia Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 52. Latin America Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 53. Latin America Ketorolac Market Share by Type (2016-2027)

    Figure 54. Latin America Ketorolac Market Share by Application (2016-2027)

    Figure 55. Latin America Ketorolac Market Share by Country (2016-2027)

    Figure 56. Mexico Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 57. Brazil Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 58. Middle East & Africa Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 59. Middle East & Africa Ketorolac Market Share by Type (2016-2027)

    Figure 60. Middle East & Africa Ketorolac Market Share by Application (2016-2027)

    Figure 61. Middle East & Africa Ketorolac Market Share by Country (2016-2027)

    Figure 62. Turkey Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 63. Saudi Arabia Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 64. UAE Ketorolac Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 65. Pfizer Revenue Growth Rate in Ketorolac Business (2016-2021)

    Figure 66. Femina Pharma Revenue Growth Rate in Ketorolac Business (2016-2021)

    Figure 67. Fuisz Pharma Revenue Growth Rate in Ketorolac Business (2016-2021)

    Figure 68. Allergan Revenue Growth Rate in Ketorolac Business (2016-2021)

    Figure 69. Technical Chemicals & Products Revenue Growth Rate in Ketorolac Business (2016-2021)

    Figure 70. Apotex Corporation Revenue Growth Rate in Ketorolac Business (2016-2021)

    Figure 71. Sichuan Meida Kangjiale Pharmaceutical Revenue Growth Rate in Ketorolac Business (2016-2021)

    Figure 72. Tianjin Hongri Pharmaceutical Revenue Growth Rate in Ketorolac Business (2016-2021)

    Figure 73. Shandong New Era Pharmaceutical Revenue Growth Rate in Ketorolac Business (2016-2021)

    Figure 74. Chengdu Better Pharmaceutical Revenue Growth Rate in Ketorolac Business (2016-2021)

    Figure 75. Yongxin Pharmaceutical Industry Revenue Growth Rate in Ketorolac Business (2016-2021)

    Figure 76. Bottom-up and Top-down Approaches for This Report

    Figure 77. Data Triangulation

    Figure 78. Key Executives Interviewed